These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 9158937)
21. [Role of the p53 and bcl-2 genes in apoptosis and drug resistance of tumors]. Luk'ianova NIu; Kulik GI; Chehun VF Vopr Onkol; 2000; 46(2):121-8. PubMed ID: 10853407 [No Abstract] [Full Text] [Related]
22. [p53 as a molecular target for cancer therapy]. Ishioka C; Osada M; Gamo M; Kanamaru R Gan To Kagaku Ryoho; 1997 Dec; 24(15):2207-12. PubMed ID: 9422063 [TBL] [Abstract][Full Text] [Related]
23. Apoptosis: basic concepts and potential significance in human cancer. Staunton MJ; Gaffney EF Arch Pathol Lab Med; 1998 Apr; 122(4):310-9. PubMed ID: 9648897 [TBL] [Abstract][Full Text] [Related]
24. Role of p53 and apoptosis in carcinogenesis. Wang XW Anticancer Res; 1999; 19(6A):4759-71. PubMed ID: 10697590 [TBL] [Abstract][Full Text] [Related]
25. Paradoxical role of apoptosis in tumor progression. Gurova KV; Gudkov AV J Cell Biochem; 2003 Jan; 88(1):128-37. PubMed ID: 12461782 [TBL] [Abstract][Full Text] [Related]
26. Contribution of p53, p63, and p73 to the developmental diseases and cancer. Tomkova K; Tomka M; Zajac V Neoplasma; 2008; 55(3):177-81. PubMed ID: 18348649 [TBL] [Abstract][Full Text] [Related]
27. p21(WAF1/CIP1) and cancer: a shifting paradigm? Gartel AL Biofactors; 2009; 35(2):161-4. PubMed ID: 19449443 [TBL] [Abstract][Full Text] [Related]
28. Oncogenic mutations of the p53 tumor suppressor: the demons of the guardian of the genome. Sigal A; Rotter V Cancer Res; 2000 Dec; 60(24):6788-93. PubMed ID: 11156366 [TBL] [Abstract][Full Text] [Related]
29. [Better understanding of the biology of cancer cells]. Klein G Ugeskr Laeger; 2000 Sep; 162(39):5199-204. PubMed ID: 11043045 [TBL] [Abstract][Full Text] [Related]
30. [Better understanding of the biology of cancer cells]. Klein G Lakartidningen; 2000 Jul; 97(28-29):3260-4. PubMed ID: 10997012 [TBL] [Abstract][Full Text] [Related]
31. [Genetic defects as markers of tumor development]. Likhtenshteĭn AV; Potapova GI Mol Biol (Mosk); 2003; 37(2):181-93. PubMed ID: 12723466 [TBL] [Abstract][Full Text] [Related]
32. [The tumor suppressor p53: "guardian of our genomes"]. Deppert W Med Monatsschr Pharm; 1999 Jun; 22(6):166-73. PubMed ID: 10394793 [No Abstract] [Full Text] [Related]
33. [2000 Standards, Options and Recommendations for prognostic value of oncogenes and tumor suppressor genes in non small cell lung cancer]. Bréchot JM; Molina T; Theobald S; Depierre A; Lagrange JL; Astoul P; Baldeyrou P; Bardet E; Bazelly B; Breton JL; Douillard JY; Grivaux M; Jacoulet P; Khalil A; Lemarié E; Martinet Y; Massard G; Milleron B; Moro-Sibilot D; Paesmans M; Pujol JL; Quoix AE; Ranfaing E; Rivière A; Sancho-Garnier H; Souquet PJ; Spaeth D; Stcebner-Delbarre A; Bull Cancer; 2002 Oct; 89(10):857-67. PubMed ID: 12441277 [TBL] [Abstract][Full Text] [Related]
34. Surfing the p53 network. Vogelstein B; Lane D; Levine AJ Nature; 2000 Nov; 408(6810):307-10. PubMed ID: 11099028 [No Abstract] [Full Text] [Related]
35. Super competition as a possible mechanism to pioneer precancerous fields. Rhiner C; Moreno E Carcinogenesis; 2009 May; 30(5):723-8. PubMed ID: 19126656 [TBL] [Abstract][Full Text] [Related]
36. DAP kinase-a proapoptotic gene that functions as a tumor suppressor. Raveh T; Kimchi A Exp Cell Res; 2001 Mar; 264(1):185-92. PubMed ID: 11237533 [No Abstract] [Full Text] [Related]
37. Oncogene-dependent tumor suppression: using the dark side of the force for cancer therapy. Evan GI; Christophorou M; Lawlor EA; Ringshausen I; Prescott J; Dansen T; Finch A; Martins C; Murphy D Cold Spring Harb Symp Quant Biol; 2005; 70():263-73. PubMed ID: 16869762 [TBL] [Abstract][Full Text] [Related]
38. Experimental control of neoplastic progression in cell populations: Foulds' rules revisited. Rubin H Proc Natl Acad Sci U S A; 1994 Jul; 91(14):6619-23. PubMed ID: 8022827 [TBL] [Abstract][Full Text] [Related]
39. The linear process of somatic evolution. Nowak MA; Michor F; Iwasa Y Proc Natl Acad Sci U S A; 2003 Dec; 100(25):14966-9. PubMed ID: 14657359 [TBL] [Abstract][Full Text] [Related]
40. Molecular biology of normal development, malignancy and its suppression. Liebermann DA Oncogene; 1996 May; 12(10):2247-50. PubMed ID: 8668352 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]